Catalyst
Slingshot members are tracking this event:
FDA Designates Viamet Pharma's (Pending:VMET) VT-1598 a Qualified Infectious Disease Product (QIDP) for Oral Treatment of Valley Fever
- Source Link:
- http://www.viamet.com/docs/PR_2016_9-15-16.pdf
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| Viamet Pharmaceuticals |
|
|
||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Sep 15, 2016
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Qualified Infectious Disease Product, Oral Treatment, Coccidiodomycosis, Valley Fever, Fast Track Status
